CN Patent

CN102614188A — 含有缬沙坦、左旋氨氯地平和氢氯噻嗪的胶囊剂及其制法

Assigned to Beijing Hasanlian Technology Co.,Ltd. · Expires 2012-08-01 · 14y expired

What this patent protects

本发明涉及一种含有缬沙坦、左旋氨氯地平和氢氯噻嗪的胶囊剂及其制法。该胶囊剂是以缬沙坦、左旋氨氯地平、氢氯噻嗪活性成分为原料，包括一种或多种可药用的赋形剂，其制备方法是将缬沙坦、氨氯地平、氢氯噻嗪和可选择的稀释剂、粘合剂、崩解剂、抗粘着剂和润滑剂，干法制粒或湿法制粒，然后填充胶囊。本发明提供的胶囊剂可用于治疗高血压，疗效显著。

USPTO Abstract

本发明涉及一种含有缬沙坦、左旋氨氯地平和氢氯噻嗪的胶囊剂及其制法。该胶囊剂是以缬沙坦、左旋氨氯地平、氢氯噻嗪活性成分为原料，包括一种或多种可药用的赋形剂，其制备方法是将缬沙坦、氨氯地平、氢氯噻嗪和可选择的稀释剂、粘合剂、崩解剂、抗粘着剂和润滑剂，干法制粒或湿法制粒，然后填充胶囊。本发明提供的胶囊剂可用于治疗高血压，疗效显著。

Drugs covered by this patent

Patent Metadata

Patent number
CN102614188A
Jurisdiction
CN
Classification
—
Expires
2012-08-01
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Hasanlian Technology Co.,Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.